The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Methicillin-resistant staphylococci
Open accessAbstract
Strains of staphylococci resistant to methicillin were identified immediately after introduction of this drug. Methicillin-resistant strains have unusual properties, the most notable of which is extreme variability in expression of the resistance trait. The conditions associated with this heterogeneous expression of resistance are described. Methicillin resistance is associated with production of a unique penicillin-binding protein (PBP), 2a, which is bound and inactivated only at high concentrations of beta-lactam antibiotics. PBP2a appears to be encoded by the mec determinant, which also is unique to methicillin-resistant strains. The relationships between PBP2a and expression of resistance and implications for the mechanism of resistance are discussed. The heterogeneous expression of methicillin resistance by staphylococci poses problems in the detection of resistant strains. Experience with several susceptibility test methods is reviewed and guidelines for performance of these tests are given. Treatment of infections caused by methicillin-resistant staphylococci is discussed. Vancomycin is the treatment of choice. Alternatives have been few because methicillin-resistant strains often are resistant to multiple antibiotics in addition to beta-lactam antibiotics. New agents which are active against methicillin-resistant staphylococci are becoming available, and their potential role in treatment is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Hartman, B. J., & Tomasz, A. (1984) · Journal of Bacteriology · doi:10.1128/jb.158.2.513-516.1984 · Cited by 890
Methicillin-resistant staphylococci
Barber, M. (1961) · Journal of Clinical Pathology · doi:10.1136/jcp.14.4.385 · Cited by 729
PENICILLIN-BINDING PROTEINS AND THE MECHANISM OF ACTION OF BETA-LACTAM ANTIBIOTICS
Waxman, D. J., & Strominger, J. L. (1983) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.52.070183.004141 · Cited by 721
Antimicrobial resistance of Staphylococcus aureus: genetic basis
Lyon, B. R., & Skurray, R. A. (1987) · Microbiological Reviews · doi:10.1128/mmbr.51.1.88-134.1987 · Cited by 686
Epidemiology of Nosocomial Infections Caused by Methicillin-Resistant Staphylococcus aureus
THOMPSON, R. L., CABEZUDO, I., & WENZEL, R. P. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-3-309 · Cited by 651
Emergence of Vancomycin Resistance in Coagulase-Negative Staphylococci
Schwalbe, R. S., Stapleton, J. T., & Gilligan, P. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704093161507 · Cited by 584
Barrett, F. F., McGehee, R. F., & Finland, M. (1968) · New England Journal of Medicine · doi:10.1056/nejm196808292790901 · Cited by 512
HALEY, R. W., HIGHTOWER, A. W., KHABBAZ, R. F., THORNSBERRY, C., MARTONE, W. J., ALLEN, J. R., & HUGHES, J. M. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-3-297 · Cited by 404
KARCHMER, A. W., ARCHER, G. L., & DISMUKES, W. E. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-4-447 · Cited by 395
Methicillin-Resistant Staphylococcus aureus: Introduction and Spread Within a Hospital
PEACOCK, J. E., MARSIK, F. J., & WENZEL, R. P. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-4-526 · Cited by 391
Crossley, K., Loesch, D., Landesman, B., Mead, K., Chern, M., & Strate, R. (1979) · Journal of Infectious Diseases · doi:10.1093/infdis/139.3.273 · Cited by 390
Utsui, Y., & Yokota, T. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.3.397 · Cited by 365
SARAVOLATZ, L. D., MARKOWITZ, N., ARKING, L., POHLOD, D., & FISHER, E. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-1-11 · Cited by 355
Matsuhashi, M., Song, M. D., Ishino, F., Wachi, M., Doi, M., Inoue, M., Ubukata, K., Yamashita, N., & Konno, M. (1986) · Journal of Bacteriology · doi:10.1128/jb.167.3.975-980.1986 · Cited by 316
Song, M. D., Wachi, M., Doi, M., Ishino, F., & Matsuhashi, M. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80373-3 · Cited by 302
SARAVOLATZ, L. D., POHLOD, D. J., & ARKING, L. M. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-3-325 · Cited by 290
Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus
Hartman, B. J., & Tomasz, A. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.1.85 · Cited by 263
Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus
SORRELL, T. C., PACKHAM, D. R., SHANKER, S., FOLDES, M., & MUNRO, R. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-3-344 · Cited by 260
Jessen, O., Rosendal, K., Bülow, P., Faber, V., & Eriksen, K. R. (1969) · New England Journal of Medicine · doi:10.1056/nejm196909182811201 · Cited by 259
A NEW TYPE OF PENICILLIN RESISTANCE OF STAPHYLOCOCCUS AUREUS
(1977) · InPharma · doi:10.1007/bf03284982 · Cited by 253
Klimek, J. J., Marsik, F. J., Bartlett, R. C., Weir, B., Shea, P., & Quintiliani, R. (1976) · The American Journal of Medicine · doi:10.1016/0002-9343(76)90370-3 · Cited by 236
Ubukata, K., Yamashita, N., & Konno, M. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.5.851 · Cited by 234
LOCKSLEY, R. M., COHEN, M. L., QUINN, T. C., TOMPKINS, L. S., COYLE, M. B., KIRIHARA, J. M., & COUNTS, G. W. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-3-317 · Cited by 230
LEVINE, D. P., CUSHING, R. D., JUI, J., & BROWN, W. J. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-3-330 · Cited by 224
Taylor, P. C., Schoenknecht, F. D., Sherris, J. C., & Linner, E. C. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.23.1.142 · Cited by 213
GROWING CLINICAL SIGNIFICANCE OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
Jack Benner, E., & Kayser, F. H. (1968) · The Lancet · doi:10.1016/s0140-6736(68)90947-1 · Cited by 206
Intrinsic resistance to β‐lactam antibiotics in staphylococcus aureus
Brown, D. F. J., & Reynolds, P. E. (1980) · FEBS Letters · doi:10.1016/0014-5793(80)80455-8 · Cited by 187
Crossley, K., Loesch, D. M., Landesman, B., et al. (1979) · Cited by 185
Crossley, K., Landesman, B., & Zaske, D. (1979) · Journal of Infectious Diseases · doi:10.1093/infdis/139.3.280 · Cited by 177
Beck, W. D., Berger-Bächi, B., & Kayser, F. H. (1986) · Journal of Bacteriology · doi:10.1128/jb.165.2.373-378.1986 · Cited by 176
A prospective study of adverse reactions associated with vancomycin therapy
Sorrell, T. C., & Collignon, P. J. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/16.2.235 · Cited by 175
In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic
Eliopoulos, G. M., Willey, S., Reiszner, E., Spitzer, P. G., Caputo, G., & Moellering, R. C. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.4.532 · Cited by 173
Altered penicillin-binding proteins in methicillin-resistant strains of Staphylococcus aureus
Hartman, B., & Tomasz, A. (1981) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.19.5.726 · Cited by 168
Craven, D. E., Reed, C. C., Kollisch, N. R., et al. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90258-8 · Cited by 160
CHARACTERISTICS OF METHICILLIN-RESISTANT STAPHYLOCOCCI
Sutherland, R., & Rolinson, G. N. (1964) · Journal of Bacteriology · doi:10.1128/jb.87.4.887-899.1964 · Cited by 159
Evolution of Natural Resistance to the Newer Penicillins
Stewart, G. T., & Holt, R. (1963) · BMJ · doi:10.1136/bmj.1.5326.308 · Cited by 159
Staphylococcus aureus Endocarditis: Combined Therapy With Vancomycin and Rifampin
Faville, R. J. (1978) · JAMA · doi:10.1001/jama.1978.03290180037019 · Cited by 158
Reynolds, P. E., & Brown, D. F. J. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80036-3 · Cited by 148
Miller, M. H., Edberg, S. C., Mandel, L., Behar, C. F., & Steigbigel, N. H. (1980) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.18.5.722 · Cited by 144
A Role in vivo for Penicillin‐Binding Protein‐4 of Staphylococcus aureus
Wyke, A. W., Ward, J. B., HAYES, M. V., & Curtis, N. A. C. (1981) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1981.tb05620.x · Cited by 136
Genetics of staphylococcal enterotoxin B in methicillin-resistant isolates of Staphylococcus aureus
Shafer, W. M., & IANDOLO, J. J. (1979) · Infection and Immunity · doi:10.1128/iai.25.3.902-911.1979 · Cited by 135
Annear, D. I. (1968) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1968.tb28631.x · Cited by 133
Serum Bactericidal Activity as a Monitor of Antibiotic Therapy
Wolfson, J. S., & Swartz, M. N. (1985) · New England Journal of Medicine · doi:10.1056/nejm198504113121507 · Cited by 131
Ward, T. T., Winn, R. E., Hartstein, A. I., & Sewell, D. L. (1981) · Infection Control · doi:10.1017/s0195941700055715 · Cited by 130
Trimethoprim-Sulfamethoxazole for Bacterial Meningitis
Levitz, R. E., & QUINTILIANI, R. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-6-881 · Cited by 126
Treatment of Infections Due to Methicillin-Resistant Staphylococcus aureus
Watanakunakorn, C. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-3-376 · Cited by 125
Georgopapadakou, N. H., SMITH, S. A., & BONNER, D. P. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.22.1.172 · Cited by 121
Bacteremia Due to Methicillin-Resistant Staphylococcus aureus
Myers, J. P., & Linnemann, C. C. (1982) · The Journal of Infectious Diseases · doi:10.1093/infdis/145.4.532 · Cited by 120
Calain, P., Krause, K.-H., Vaudaux, P. E., Auckenthaler, R., Lew, D., Waldvogel, F. A., & Hirschel, B. J. (1987) · The Journal of Infectious Diseases · doi:10.1093/infdis/155.2.187 · Cited by 119
Chambers, H. F. “., Hartman, B. J., & Tomasz, A. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111965 · Cited by 113
Self-citationAntibiotic Tolerance Among Clinical Isolates of Bacteria
Handwerger, S., & Tomasz, A. (1985) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.25.040185.002025 · Cited by 109
CURRENT STATUS OF METHICILLIN, OXACILLIN, AND CLOXACILLIN.
Acar, J. F., Courvalin, P. M., & CHABBERT, Y. A. (1964) · PubMed · Cited by 108
Gopal, V. (1976) · JAMA · doi:10.1001/jama.236.14.1604 · Cited by 108
Chromosomal map location of the methicillin resistance determinant in Staphylococcus aureus
Kuhl, S. A., Pattee, P. A., & Baldwin, J. N. (1978) · Journal of Bacteriology · doi:10.1128/jb.135.2.460-465.1978 · Cited by 104
Penicillin Tolerance in Multiply Drug-Resistant Natural Isolates of Streptococcus pneumoniae
Liu, H. H., & Tomasz, A. (1985) · The Journal of Infectious Diseases · doi:10.1093/infdis/152.2.365 · Cited by 95
Chambers, H. F. “., & Hackbarth, C. J. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.12.1982 · Cited by 95
Self-citationHackbarth, C. J., Chambers, H. F. “., & Sande, M. A. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.4.611 · Cited by 93
Self-citationWatanakunakorn, C., & Tisone, J. C. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.22.5.903 · Cited by 91
Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin
Greenberg, R. N., Kennedy, D. J., Reilly, P. M., Luppen, K. L., Weinandt, W. J., Bollinger, M., Aguirre, F., Kodesch, F., & Saeed, A. M. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.2.151 · Cited by 89
Extrachromosomal Control of Methicillin Resistance and Toxin Production in Staphylococcus aureus
Dornbusch, K., Hallander, H. O., & Löfquist, F. (1969) · Journal of Bacteriology · doi:10.1128/jb.98.2.351-358.1969 · Cited by 85
Miller, M. H., Wexler, M. A., & Steigbigel, N. H. (1978) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.14.3.336 · Cited by 85
Chambers, H. F. “. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.12.1919 · Cited by 85
Self-citationThe Efficacy of Rifampin as Adjunctive Therapy in Selected Cases of Staphylococcal Endocarditis
Massanari, R. M., & Donta, S. T. (1978) · CHEST Journal · doi:10.1378/chest.73.3.371 · Cited by 85
Dyke, K. G. H. (1969) · Journal of Medical Microbiology · doi:10.1099/00222615-2-3-261 · Cited by 78
Best, G. K., Best, N. H., & Koval, A. V. (1974) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.6.6.825 · Cited by 74
Methicillin resistance of Staphylococcus aureus and Staphylococcus epidermidis.
Sabath, L. D., Ff, B., Wilcox, C., Gerstein, D. A., & Finland, M. (1968) · PubMed · Cited by 74
Sjöström, J.-E., Löfdahl, S., & Philipson, L. (1975) · Journal of Bacteriology · doi:10.1128/jb.123.3.905-915.1975 · Cited by 73
Berger‐Bächi, B., & Kohler, M. (1983) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1983.tb00137.x · Cited by 72
Clinical Study of Combination Therapy with Oxacillin and Rifampin for Staphylococcal Infections
van der Auwera, P., Meunier-Carpentier, F., & Klastersky, J. A. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.supplement_3.s515 · Cited by 69
COLEMAN, D. L., Horwitz, R. I., & Andriole, V. T. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90188-7 · Cited by 64
Resistance heterogeneity in methicillin-resistantStaphylococcus aureus
Matthews, P., & Stewart, P. R. (1984) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1984.tb00718.x · Cited by 63
Antibiotic Therapy of Experimental Staphylococcus epidermidis Endocarditis
Vázquez, G. J., & Archer, G. L. (1980) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.17.2.280 · Cited by 59
Bibler, M. R., Frame, P. T., Hagler, D. N., Bode, R. B., Staneck, J. L., Thamlikitkul, V., Harris, J., Haregewoin, A., & Bullock, W. E. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.2.207 · Cited by 58
Intravenous trimethoprim-sulfamethoxazole in the treatment of serious infections in children
Ardati, K. O., Thirumoorthi, M. C., & Dajani, A. S. (1979) · The Journal of Pediatrics · doi:10.1016/s0022-3476(79)80740-4 · Cited by 56
Genetic behavior of the methicillin resistance determinant in Staphylococcus aureus
Stewart, G. C., & Rosenblum, E. D. (1980) · Journal of Bacteriology · doi:10.1128/jb.144.3.1200-1202.1980 · Cited by 52
Chambers, H. F. “., & Sande, M. A. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.1.61 · Cited by 51
Self-citationChambers, H. F. “., Hackbarth, C. J., Drake, T. A., Rusnak, M. G., & Sande, M. A. (1984) · The Journal of Infectious Diseases · doi:10.1093/infdis/149.6.894 · Cited by 49
Self-citationSullam, P. M., Täuber, M. G., Hackbarth, C. J., Chambers, H. F. “., Scott, K. G., & Sande, M. A. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.5.685 · Cited by 48
Self-citationBacteremia due to Methicillin-Resistant Staphylococcus aureus
Holubar, M. K., Meng, L., & Deresinski, S. C. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.02.009 · Cited by 46
Dowling, H. F. (1961) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt196125572 · Cited by 46
Methicillin—resistant staphylococcus aureus (United States)
Wenzel, R. P., Donowitz, L. G., & Miller, G. B. (1982) · Journal of Infection · doi:10.1016/s0163-4453(82)93485-5 · Cited by 45
Methicillin-Resistant Staphylococci: Genetics of the Minority Population
Seligman, S. J. (1966) · Journal of General Microbiology · doi:10.1099/00221287-42-2-315 · Cited by 44
Synthesis of Peptidoglycan in vivo in Methicillin‐Resistant Staphylococcus aureus
Wyke, A. W., Ward, J. B., & HAYES, M. V. (1982) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1982.tb06907.x · Cited by 43
Elwell, L. P., Wilson, H. R., Knick, V. B., & Keith, B. R. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.6.1092 · Cited by 43
SPONTANEOUS LOSS OF METHICILLIN RESISTANCE IN STAPHYLOCOCCUS AUREUS AT ROOM-TEMPERATURE
Grubb, W. B., & Annear, D. I. (1972) · The Lancet · doi:10.1016/s0140-6736(72)92315-x · Cited by 34
Carpenter, T. C., Hackbarth, C. J., Chambers, H. F. “., & Sande, M. A. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.3.382 · Cited by 33
Self-citationWilkinson, B. J., DORIAN, K. J., & Sabath, L. D. (1978) · Journal of Bacteriology · doi:10.1128/jb.136.3.976-982.1978 · Cited by 30
Chambers, H. F. “., & Miller, M. H. (1987) · The Journal of Infectious Diseases · doi:10.1093/infdis/155.3.581 · Cited by 28
Self-citationStewart, G. C., & Rosenblum, E. D. (1980) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.18.3.424 · Cited by 26
Gilbert, M., Boscia, J. A., Kobasa, W. D., & Kaye, D. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.3.461 · Cited by 26
Altered Cell Walls of Staphylococcus aureus resistant to Methicillin
Sabath, L. D., Leaf, C. D., Gerstein, D. A., & Finland, M. (1970) · Nature · doi:10.1038/2251074a0 · Cited by 24
Smith, P. F., & Wilkinson, B. J. (1981) · Journal of Bacteriology · doi:10.1128/jb.148.2.610-617.1981 · Cited by 21
Lack of reproducibility of macrodilution MBCs for Staphylococcus aureus
Pelletier, L. L. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.6.815 · Cited by 20
Wilkinson, B. J., & Nadakavukaren, M. J. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.23.4.610 · Cited by 16
Cited by
Wiegand, I., Hilpert, K., & Hancock, R. E. W. (2008) · Nature Protocols · doi:10.1038/nprot.2007.521 · Cited by 6,156
The crisis in antibiotic resistance
Neu, H. C. (1992) · Science · doi:10.1126/science.257.5073.1064 · Cited by 2,834
Magnetic nanoparticles: biomedical applications and challenges
Tran, N., & Webster, T. J. (2010) · Journal of Materials Chemistry · doi:10.1039/c0jm00994f · Cited by 459
Ziebuhr, W., Heilmann, C., Götz, F., Meyer, P., Wilms, K., Straube, E., & Hacker, J. (1997) · Infection and Immunity · doi:10.1128/iai.65.3.890-896.1997 · Cited by 368
Blumberg, H. M., Rimland, D., Carroll, D. J., Terry, & Wachsmuth, I. K. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.6.1279 · Cited by 319
Metadata
- Authors
- Chambers, H. F.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 1988-04
- Volume
- 1
- Issue
- 2
- Pages
- 173-186
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W1876295475
- Cited by
- 274
- References
- 95
- FWCI
- 11.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.